MTOR and breast cancer: In this study, we have evaluated the relationship between activated mTOR signaling and the ERα phosphorylation score, as a measure of the balance of ligand-dependent and -independent ERα signaling, using human breast cancer cases, where the patient subsequently received adjuvant tamoxifen therapy.